CHEK2 and breast cancer: Moreover, the mean age at primary breast cancer diagnosis for CHEK2 carriers of truncating variants (excluding carriers of large genomic rearrangements) and CHEK2 carriers of missense variants was 43.88 years [6.83] and 40.12 years [5.8], respectively.